Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device

ST2 and Patient Prognosis in Chronic Heart Failure

(2015) Antoni Bayes-Genis et al.   AMERICAN JOURNAL OF CARDIOLOGY

The Biology of ST2: The International ST2 Consensus Panel

(2015) Domingo A. Pascual-Figal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Soluble ST2 in heart failure

(2015) Benjamin Dieplinger et al.   CLINICA CHIMICA ACTA

State of the Art: Newer biomarkers in heart failure

(2015) Rudolf A. de Boer et al.   EUROPEAN JOURNAL OF HEART FAILURE

Soluble ST2 reflects hemodynamic stress in non-ischemic heart failure

(2015) Kaspar Broch et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation

(2015) Ernesto Martínez-Martínez et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33

(2015) Wei-Yu Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results

(2013) Alan H.B. Wu et al.   AMERICAN HEART JOURNAL

Heart Failure Therapy–Induced Early ST2 Changes May Offer Long-Term Therapy Guidance

(2013) Tobias Breidthardt et al.   JOURNAL OF CARDIAC FAILURE

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

(2012) Kaspar Broch et al.   EUROPEAN JOURNAL OF HEART FAILURE

Association of ST2 levels with cardiac structure and function and mortality in outpatients

(2010) Lori B. Daniels et al.   AMERICAN HEART JOURNAL

A catalogue of reporting guidelines for health research

(2009) I. Simera et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Serial Sampling of ST2 Predicts 90-Day Mortality Following Destabilized Heart Failure

(2008) Saskia Boisot et al.   JOURNAL OF CARDIAC FAILURE